Sydney Lupkin Sydney Lupkin is the pharmaceuticals correspondent for NPR.
Stories By

Sydney Lupkin

Sydney Lupkin

Pharmaceuticals Correspondent

Sydney Lupkin is the pharmaceuticals correspondent for NPR.

She was most recently a correspondent at Kaiser Health News, where she covered drug prices and specialized in data reporting for its enterprise team. She's reported on how tainted drugs can reach consumers, how companies take advantage of rare disease drug rules and how FDA-approved generics often don't make it to market. She's also tracked pharmaceutical dollars to patient advocacy groups and members of Congress. Her work has won the National Press Club's Joan M. Friedenberg Online Journalism Award, the National Institute for Health Care Management's Digital Media Award and a health reporting award from the Society for Advancing Business Editing and Writing.

Lupkin graduated from Boston University. She's also worked for ABC News, VICE News, MedPage Today and The Bay Citizen. Her internship and part-time work includes stints at ProPublica, The Boston Globe, The Boston Herald, The New England Center for Investigative Reporting and WCVB.

[+] read more[-] less

Story Archive

Novavax released its federal contract to develop and supply a COVID-19 vaccine. The agreement reveals terms that weren't previously known. Bloomberg via Getty Images hide caption

toggle caption
Bloomberg via Getty Images

The Department of Health and Human Services on Saturday made public several contracts with companies working on COVID-19 vaccines as part of Operation Warp Speed. Mark Wilson/Getty Images hide caption

toggle caption
Mark Wilson/Getty Images

Regeneron has developed a drug called REGN-COV2 that is a combination of two monoclonal antibodies that block the virus that causes COVID-19. The company has a contract to supply up to 300 million doses to the U.S. government. Lev Radin/Pacific Press/LightRocket via Getty Images hide caption

toggle caption
Lev Radin/Pacific Press/LightRocket via Getty Images

Moncef Slaoui, a former GlaxoSmithKline executive, speaks during the kickoff announcement for Operation Warp Speed in the White House Rose Garden on May 15. Jabin Botsford/The Washington Post via Getty Images hide caption

toggle caption
Jabin Botsford/The Washington Post via Getty Images

After Months Of Questions, A Key Operation Warp Speed Adviser's Contract Emerges

  • Download
  • <iframe src="https://www.npr.org/player/embed/929284620/929609229" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A heavily redacted supply contract between the federal government and vaccine developer Moderna, headquartered in Cambridge, Mass., was released Friday. Joseph Prezioso/AFP via Getty Images hide caption

toggle caption
Joseph Prezioso/AFP via Getty Images

FDA Panel To Lay Regulatory Groundwork For COVID-19 Vaccine

  • Download
  • <iframe src="https://www.npr.org/player/embed/926537946/926537947" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A Look At Why Johnson & Johnson Paused Coronavirus Vaccine Trial

  • Download
  • <iframe src="https://www.npr.org/player/embed/923377223/923377224" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A volunteer received an injection as part of a clinical trial for a COVID-19 vaccine at Research Centers of America in Hollywood, Fla. Studies of vaccines backed by Operation Warp Speed have enrolled tens of thousands of people in a matter of months. Bloomberg/Bloomberg via Getty Images hide caption

toggle caption
Bloomberg/Bloomberg via Getty Images

A volunteer in a clinical trial for an experimental COVID-19 vaccine receives an injection last month at Research Centers of America in Hollywood, Fla. Eva Marie Uzcategui/Bloomberg via Getty Images hide caption

toggle caption
Eva Marie Uzcategui/Bloomberg via Getty Images

President Trump announced the creation of Operation Warp Speed in May to fast-track a coronavirus vaccine. He called it "a massive scientific and industrial, logistic endeavor unlike anything our country has seen since the Manhattan Project." Drew Angerer/Getty Images hide caption

toggle caption
Drew Angerer/Getty Images

How Operation Warp Speed's Big Vaccine Contracts Could Stay Secret

  • Download
  • <iframe src="https://www.npr.org/player/embed/917899357/918317595" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

CDC Releases Plan For Coronavirus Vaccine Distribution

  • Download
  • <iframe src="https://www.npr.org/player/embed/913693771/913693772" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

9 Companies Pledge Not To Submit Coronavirus Vaccine To FDA Until It's Proved Safe

  • Download
  • <iframe src="https://www.npr.org/player/embed/910788743/910788744" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript